Experience in Ocaña, Norte de Santander, with a Scale for Visualization of the Gastric Mucosa during Esophagogastroduodenoscopy in Patients Medicated with N-acetylcysteine plus Simethicone
DOI:
https://doi.org/10.22516/25007440.226Keywords:
Premedication, endoscopy, simethicone, N-acetylcysteineAbstract
Introduction: During upper digestive tract endoscopy, visibility of the gastric mucosa can be limited by adherent mucus and bubbles.
Objectives: This is a study of visualization of the gastric mucosa and the number of washes needed to clear bubbles and foam from the gastric surface. The modified Kuo scale by Chang was used with patients medicated prior to esophagogastroduodenoscopy.
Materials and methods: This is a descriptive and prospective study of 120 patients who were medicated with 400 mg (10cc) of 4% N-acetylcysteine plus 133.3 mg (2cc) of simethicone (Dimethylpolysiloxane) and 100 cc of warm water 20 minutes prior to esophagogastroduodenoscopy from October to December 2016. Data were tabulated in Excel and frequencies and percentages were analyzed using the Epi Info statistical package from the Centers for Disease Control version 7.2 for Windows. Statistical significance was considered to be p <0.05.
Results: The optimal score for total visibility of four was achieved 57 patients (47.50%). Thirty-six patients (30%) had scores of five points, ten patients (8.33%) had scores of six or seven points, six patients had scores of eight points (5%), and one patient (0.83%) had a score of nine points. There were no scores from 10 to 16. Hundred patients (83,3%) did not need additional washes with water to visualize the gastric mucosa, thirteen patients (10,83%) required less than 50 cc, and seven (5,83%) required more than 50 cc (p = 0.00).
Limitations: This study was done by a single observer which could result in detection biases. Also, the sample is small.
Conclusions: Administration of a solution of N-acetylcysteine plus Simethicone diluted in 100 cc of warm water prior to upper digestive tract endoscopy provides for optimal visualization of the gastric mucosa in most cases. A smaller volume of water was needed to clear the gastric cavity of mucus and foam.Downloads
Languages:
enReferences
Dinis-Ribeiro M, da Costa-Pereira A, Lopes C, et al. Magnification chromoendoscopy for the diagnosis of gastric intestinal metaplasia and dysplasia. Gastrointest Endosc. 2003;57(4):498-504.
https://doi.org/10.1067/mge.2003.145
McDonald GB, O'Leary R, Stratton C. Pre-endoscopic use of oral simethicone. Gastrointest Endosc. 1978;24(6):283.
https://doi.org/10.1016/S0016-5107(78)73542-X
Fujii T, Iishi H, Tatsuta M, et al. Effectiveness of premedication with pronase for improving visibility during gastroendoscopy: a randomized controlled trial. Gastrointest Endosc. 1998;47(5):382-7. https://doi.org/10.1016/S0016-5107(98)70223-8
Kim GH, Cho YK, Cha JM, et al. Efforts to increase image quality during endoscopy: The role of pronase. World J Gastrointest Endosc. 2016;8(5):267-72.
https://doi.org/10.4253/wjge.v8.i5.267
Ahsan M, Babaei L, Gholamrezaei A, Emami MH. Simethicone for the preparation before esophagogastroduodenoscopy. Diagn Ther Endosc. 2011;2011:484532.
https://doi.org/10.1155/2011/484532
Tse HN, Tseng CZ. Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014;9:825-36.
https://doi.org/10.2147/COPD.S51057
Wu L, Cao Y, Liao C, et al. Systematic review and meta-analysis of randomized controlled trials of Simethicone for gastrointestinal endoscopic visibility. Scand J Gastroenterol. 2011;46(2):227-35.
https://doi.org/10.3109/00365521.2010.525714
Chang CC, Chen SH, Lin CP, et al. Premedication with pronase or N-acetylcysteine improves visibility during gastroendoscopy: an endoscopist-blinded, prospective, randomized study. World J Gastroenterol. 2007;13(3):444-7.
https://doi.org/10.3748/wjg.v13.i3.444
Gómez M, Riveros J, Ruiz O, et al. Guía de práctica clínica para la prevención, diagnóstico y tratamiento del cáncer gástrico temprano-2015. Rev Col Gastroenterol. 2015;30 supl 1:34-42.
Rollan A, Cortés D, Calvo A, et al. Diagnóstico precoz de cáncer gástrico. Propuesta de detección y seguimiento de lesiones premalignas gástricas: protocolo ACHED. Rev Med Chile. 2014;142(9):1181-92.
https://doi.org/10.4067/S0034-98872014000900013
Emura F, Mejía J, Mejía M, et al. Utilidad de la cromoendoscopia sistemática el diagnóstico del cáncer temprano y lesiones gástricas premalignas, resultado de dos campa-as masivas consecutivas de tamizaje en Colombia (2006-2007). Rev Col Gastroenterol. 2010;25(1):19-30.
Kuo CH, Sheu BS, Kao AW, et al. A defoaming agent should be used with pronase premedication to improve visibility in upper gastrointestinal endoscopy. Endoscopy. 2002;34(7):531-4.
https://doi.org/10.1055/s-2002-33220
McNally PR, Maydonovitch CL, Wong RK. The effectiveness of simethicone in improving visibility during colonoscopy: a double-blind randomized study. Gastrointest Endosc. 1988;34(3):255-8.
https://doi.org/10.1016/S0016-5107(88)71324-3
Mansilla R, Uslar T, Chahuán J, et al. Validez y confiabilidad de una escala de clasificación de limpieza gástrica en endoscopia digestiva alta en población chilena. Gastroentrol Latinoam. 2016;27(1):9-17.
Kim GH, Cho YK, Cha JM, et al. Effect of pronase as mucolytic agent on imaging quality of magnifying endoscopy. World J Gastroenterol. 2015;21(8):2483-9.
https://doi.org/10.3748/wjg.v21.i8.2483
Lee GJ, Park SJ, Kim SJ, et al. Effectiveness of Premedication with Pronase for Visualization of the Mucosa during Endoscopy: A Randomized, Controlled Trial. Clin Endosc. 2012;45(2):161-4.
https://doi.org/10.5946/ce.2012.45.2.161
Chang CC, Chen SH, Lin CP, et al. Premedication with pronase or N-acetylcysteine improves visibility during gastroendoscopy: an endoscopist-blinded, prospective, randomized study. World J Gastroenterol. 2007;13(3):444-7.
https://doi.org/10.3748/wjg.v13.i3.444
Wang C, Liu H, Wang X, et al. Benefit of a 360-degree horizontal turn following premedication with simethicone on image quality during gastroendoscopy: a randomized controlled trial. Int J Clin Exp Med. 2015;8(3):4281-6.
Song M, Kwek AB, Law NM, et al. Efficacy of small-volume simethicone given at least 30 min before gastroscopy. World J Gastrointest Pharmacol Ther. 2016;7(4):572-8.
https://doi.org/10.4292/wjgpt.v7.i4.572
Asl SM, Sivandzadeh GR. Efficacy of premedication with activated Dimethicone or N-acetylcysteine in improving visibility during upper endoscopy. World J Gastroenterol. 2011;17(37):4213-7.
https://doi.org/10.3748/wjg.v17.i37.4213
Elvas L, Areia M, Brito D, et al. Premedication with simethicone and N-acetylcysteine in improving visibility during upper endoscopy: a double-blind randomized trial. Endoscopy. 2017;49(2):139-45.
Neale JR, James S, Callaghan J, et al. Premedication with N-acetylcysteine and simethicone improves mucosal visualization during gastroscopy: a randomized, controlled, endoscopist-blinded study. Eur J Gastroenterol Hepatol. 2013;25(7):778-83.
https://doi.org/10.1097/MEG.0b013e32836076b2
Chang WK, Yeh MK, Hsu HC, et al. Efficacy of simethicone and N-acetylcysteine as premedication in improving visibility during upper endoscopy. J Gastroenterol Hepatol. 2014;29(4):769-74.
https://doi.org/10.1111/jgh.12487
Basford PJ, Brown J, Gadeke L, et al. A randomized controlled trial of pre-procedure simethicone and N-acetylcysteine to improve mucosal visibility during gastroscopy - NICEVIS. Endosc Int Open. 2016;4(11):E1197-E1202.
Downloads
Published
How to Cite
Issue
Section
License
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
Los autores/as ceden sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación en esta revista.
Los contenidos están protegidos bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
